Journal of Clinical Microbiology, April 1999, p. 1130-1136, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Jahurul Islam Medical College Hospital,
Received 13 October 1998/Returned for modification 4 December
1998/Accepted 7 January 1999
Commercial sex workers (CSWs) serve as the most important reservoir
of sexually transmitted diseases (STD), including gonorrhea. Periodic
monitoring of the antimicrobial susceptibility profile of
Neisseria gonorrhoeae in a high-risk population provides
essential clues regarding the rapidly changing pattern of antimicrobial susceptibilities. A study concerning the prevalence of gonococcal infection among CSWs was conducted in Bangladesh. The isolates were
examined with regards to their antimicrobial susceptibility to, and the
MICs of, penicillin, tetracycline, ciprofloxacin, cefuroxime,
ceftriaxone, and spectinomycin by disk diffusion and agar dilution
methods. The total plasmid profile of the isolates was also analyzed.
Of the 224 CSWs, 94 (42%) were culture positive for N. gonorrhoeae. There was a good correlation between the results of
the disk diffusion and agar dilution methods. Some 66% of the isolates
were resistant to penicillin, and 34% were moderately susceptible to
penicillin. Among the resistant isolates, 23.4% were
penicillinase-producing N. gonorrhoeae (PPNG). 60.6% of
the isolates were resistant and 38.3% were moderately susceptible to
tetracycline, 17.5% were tetracycline-resistant N. gonorrhoeae, 11.7% were resistant and 26.6% had reduced
susceptibility to ciprofloxacin, 2.1% were resistant and 11.7% had
reduced susceptibility to cefuroxime, and 1% were resistant to
ceftriaxone. All PPNG isolates contained a 3.2-MDa African type of
plasmid, and a 24.2-MDa conjugative plasmid was present in 34.1% of
the isolates. Since quinolones such as ciprofloxacin are recommended as
the first line of therapy for gonorrhea, the emergence of significant
resistance to ciprofloxacin will limit the usefulness of this drug for
treatment of gonorrhea in Bangladesh.
*
Corresponding author. Mailing address: Laboratory
Sciences Division, ICDDR,B, GPO Box-128, Dhaka-1000, Bangladesh. Phone: 880-2-871751-60. Fax: 880-2-872529. E-mail:
motiur{at}icddrb.org.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|